[
    [
        {
            "time": "2020-10",
            "original_text": "上海证券交易所在10月份发布的投资组合报告",
            "features": {
                "keywords": [
                    "新冠肺炎",
                    "检测板块",
                    "午后",
                    "回吐",
                    "涨幅",
                    "金域医学",
                    "丽珠集团",
                    "万泰生物"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上海证券交易所在10月份发布的投资组合报告",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 4,
                "Source_Recency": 6
            }
        }
    ]
]